Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00797043
Other study ID # UFPTI 0606-SK01
Secondary ID
Status Terminated
Phase N/A
First received November 24, 2008
Last updated February 3, 2017
Start date September 2008
Est. completion date July 2015

Study information

Verified date February 2017
Source University of Florida
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to collect information from the questionnaire and your medical records to see what effects the proton radiation has on you and your cancer and collect and analyze morbidity outcomes: Incidence of xerostomia (dry mouth) and tumor control.


Description:

Data collection will be obtained from the patient's medical records including initial evaluation, pathology report, dosimetry information, radiotherapy completion records and follow-up.


Recruitment information / eligibility

Status Terminated
Enrollment 11
Est. completion date July 2015
Est. primary completion date July 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Carcinoma of the skin of the head and neck region with incidental or symptomatic perineural invasion.

- Biopsy-proven squamous cell carcinoma.

- Will receive treatment with proton radiation.

Exclusion Criteria:

- Evidence of distant metastasis.

- Previous irradiation for head and neck cancer.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States University of Florida Proton Therapy Institute Jacksonville Florida

Sponsors (1)

Lead Sponsor Collaborator
University of Florida

Country where clinical trial is conducted

United States, 

References & Publications (9)

Al-Othman MO, Mendenhall WM, Amdur RJ. Radiotherapy alone for clinical T4 skin carcinoma of the head and neck with surgery reserved for salvage. Am J Otolaryngol. 2001 Nov-Dec;22(6):387-90. — View Citation

BALLANTYNE AJ, MCCARTEN AB, IBANEZ ML. THE EXTENSION OF CANCER OF THE HEAD AND NECK THROUGH PERIPHERAL NERVES. Am J Surg. 1963 Oct;106:651-67. — View Citation

Bhandare N, Monroe AT, Morris CG, Bhatti MT, Mendenhall WM. Does altered fractionation influence the risk of radiation-induced optic neuropathy? Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1070-7. — View Citation

Cottel WI. Perineural invasion by squamous-cell carcinoma. J Dermatol Surg Oncol. 1982 Jul;8(7):589-600. — View Citation

Mendenhall WM, Amdur RJ, Siemann DW, Parsons JT. Altered fractionation in definitive irradiation of squamous cell carcinoma of the head and neck. Curr Opin Oncol. 2000 May;12(3):207-14. Review. — View Citation

Mendenhall WM, Amdur RJ, Williams LS, Mancuso AA, Stringer SP, Price Mendenhall N. Carcinoma of the skin of the head and neck with perineural invasion. Head Neck. 2002 Jan;24(1):78-83. Review. — View Citation

Mendenhall WM, Parsons JT, Mendenhall NP, Brant TA, Stringer SP, Cassisi NJ, Million RR. Carcinoma of the skin of the head and neck with perineural invasion. Head Neck. 1989 Jul-Aug;11(4):301-8. — View Citation

Mendenhall WM, Parsons JT, Mendenhall NP, Million RR. T2-T4 carcinoma of the skin of the head and neck treated with radical irradiation. Int J Radiat Oncol Biol Phys. 1987 Jul;13(7):975-81. — View Citation

Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR. Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys. 1994 Nov 15;30(4):755-63. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Collect and analyze morbidity outcomes: Incidence of grade 3 or higher xerostomia (dry mouth) 1 year following the completion of radiation therapy
Secondary Collect and analyze tumor control outcomes. When each patient has been followed for a minimum of 6 months and then again at 24 months.